The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...

Following strong gains in Q3, the Russell 1000® Value Index finished slightly lower in Q4, declining -1.98%. For the year, ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA, ...